Both in Pharmaceuticals
Trevi Therapeutics vs Zenas BioPharma
Over the past year TRVI returned +16.3% and ZBIO returned −9.2%; their daily moves had a correlation of 0.27.
TRVI +16.3% ZBIO −9.2%Growth of $1, one year, split-adjusted
| Metric | TRVI | ZBIO |
|---|---|---|
| Price | $13.56 | $28.39 |
| Market cap | $1.93B | $1.85B |
| Today | −1.81% | −1.29% |
| 1 month | −4.4% | +1.6% |
| 6 months | −2.2% | +46.6% |
| Year to date | +8.3% | −21.8% |
| 1 year | +28.2% | +1.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1,850.4× |
| Net cash | $318.9M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 39.6% | 55.5% |
| Short % of float | 14.4% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).